Embecta Corp. (EMBC): Capital Expenditures

Annual figures by period end, from SEC filings.

$9.30M
Year ended 2025-09-30
$9.50M
Trailing 12 months to 2026-06-30
-26.7%
3-year compound annual growth
-26.0%
5-year compound annual growth
$41.90M2020-09-30: $41.90M2021-09-30: $36.80M2022-09-30: $23.60M2023-09-30: $26.50M2024-09-30: $15.80M2025-09-30: $9.30M$9.30M
2020-09-30 Capital Expenditures (USD) 2025-09-30
Period endedCapital ExpendituresChange YoYSource filing
2025-09-30$9.30M-41.1%2025-11-25, From 2024-10-01
2024-09-30$15.80M-40.4%2025-11-25, From 2023-10-01
2023-09-30$26.50M+12.3%2025-11-25, From 2022-10-01
2022-09-30$23.60M-35.9%2024-12-11, From 2021-10-01
2021-09-30$36.80M-12.2%2023-11-29, From 2020-10-01
2020-09-30$41.90Mn/a2022-12-22, From 2019-10-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Embecta Corp. (EMBC)2025-09-30$9.30M-41.1%
Tandem Diabetes Care Inc (TNDM)2025-12-31$19.95M+3.7%
Inspire Medical Systems, Inc. (INSP)2025-12-31$38.50M-1.6%
Haemonetics Corp (HAE)2026-03-28$32.78M-16.5%
Penumbra Inc (PEN)2025-12-31$63.73M+200.9%
Orthofix Medical Inc. (OFIX)2025-12-31$34.63M-0.7%
Merit Medical Systems Inc (MMSI)2025-12-31$81.72M+132.5%
Alphatec Holdings, Inc. (ATEC)2025-12-31$42.45M-49.0%
iRhythm Holdings, Inc. (IRTC)2025-12-31$46.34M+36.5%

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗